This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Today's Small-Cap Winners & Losers

Innodata Isogen (INOD) soared almost 60% after the Hackensack, N.J.-based Internet-technology company said it had signed about $9 million worth in service contracts, mostly with major publishers, bringing known 2007 revenue to about $40 million so far. Shares were up $1.21 to $3.23.

Insmed (INSM) shares were leaping after the Italian government requested that its Iplex drug be made available for treatment of Lou Gehrig's disease in Italy. Cephalon (CEPH), which holds the European patent rights to that use of Iplex, will distribute the drug through a government program, and Insmed will see unspecified payments from the Italian Health Authorities. Richmond, Va.-based Insmed was rising 18 cents, or 17.5%, to $1.21. Cephalon shares were dipping 66 cents to $69.56.

Genomic Health (GHDX) surged on word that insurance giant UnitedHealth Group (UNH) had agreed to cover the biotech's Oncotype DX test service, which predicts disease recurrence and chemotherapy effectiveness for breast cancer patients. California-based Genomic was up $3.52, or 17%, to $24.20. UnitedHealth shares were unchanged.

Cosi (COSI) gained after the restaurant chain estimated that 2006 losses had narrowed by a dime a share from 2005 to 18 cents. Analysts are seeking a loss of 25 cents, according to Thomson Financial. Revenue totals for the quarter and year won't quite meet Street projections, but the Deerfield, Ill., company also forecast 2007 earnings between 8 cents and 12 cents a share, which would quash the downside consensus. Shares were adding 62 cents, or 11.8%, to $5.89.

Scientific-instruments maker LeCroy (LCRY) fell after it predicted $38 million revenue in the fiscal second quarter ended Dec. 31 -- $4 million less than last year and $4.5 million short of analysts' projections. On a GAAP basis it will probably lose $8 million, including costs related to its October acquisition of Catalyst Enterprises and stock-based compensation, reversing $2.2 million profits a year ago. Shares were down $1.28, or 11.2%, to $10.15.

Active Power (ACPW) sank after the Austin-based power-products maker announced it will conduct an internal review of its historical stock option grants, which could delay the filing of its annual report should any "significant issues" arise. Shares were losing 20 cents, or 7.7%, to $2.40.

Adaptec (ADPT) dropped after preliminary fiscal third-quarter results were short of expectations. The Milipitas, Calf., storage company expects losses by both GAAP and non-GAAP measures, missing the penny-a-share earnings estimate and the company's own prior guidance. Sales, likely between $60 million and $61 million, will also miss the $72.6 million Wall Street projections. Shares were sliding 34 cents, or 7.6%, to $4.16.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,067.56 -30.89 -0.18%
S&P 500 2,002.28 -1.09 -0.05%
NASDAQ 4,598.1880 +17.9170 0.39%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs